Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $64.89 USD
Change Today +0.23 / 0.36%
Volume 4.9M
As of 8:04 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by BRISTOL-MYERS SQUIBB CO (BMY) in the last 6 months

Announced 02/23/15
1.25B for Flexus Biosciences, Inc.

Bristol-Myers Squibb Company (NYSE:BMY) entered into a definitive agreement to acquire Flexus Biosciences, Inc. from The Column Group LLC and others for $1.2 billion on February 23, 2015. Under the terms, Bristol-Myers Squibb Company will pay $800 million upfront and upto $450 million of milestone payment. The transaction has been approved by the Boards of Directors of Bristol-Myers Squibb Company and Flexus Biosciences, Inc. the stockholders of Flexus Biosciences, Inc. ...
Read More

BMY's price was unchanged after the transaction was announced on 02/23/15.
Investor / Buyer
Bristol-Myers Squibb Company
Creditor / Lender
Celgene Corporation
Kleiner Perkins Caufield & Byers
The Column Group LLC
Financial Advisor
Citigroup Inc.
Legal Advisor
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMY:US $64.89 USD +0.23

BMY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $70.77 USD -0.46
Celgene Corp $132.14 USD -3.28
Eli Lilly & Co $85.09 USD -0.59
Medtronic PLC $77.88 USD +0.41
Novo Nordisk A/S kr400.00 DKK +7.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BMY Industry Range
Price/Earnings 60.5x
Price/Sales 6.6x
Price/Book 7.1x
Price/Cash Flow 60.2x
TEV/Sales 5.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at